KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Date Action Amount Person Type
Apr 01, 2024 Sell 19 410 Woltosz Walter S Common Stock
Apr 01, 2024 Sell 590 Woltosz Walter S Common Stock
Mar 28, 2024 Buy 30 000 Szot Daniel Stock Options (Right to Buy)
Mar 01, 2024 Sell 17 600 Woltosz Walter S Common Stock
Mar 01, 2024 Sell 2 400 Woltosz Walter S Common Stock
Feb 02, 2024 Sell 1 055 Woltosz Walter S Common Stock
Feb 01, 2024 Sell 18 645 Woltosz Walter S Common Stock
Feb 01, 2024 Sell 300 Woltosz Walter S Common Stock
Feb 01, 2024 Buy 792 Paglia John Kenneth Common Stock
Feb 01, 2024 Buy 792 Weiner Daniel L Common Stock
Feb 01, 2024 Buy 792 Woltosz Walter S Common Stock
Feb 01, 2024 Buy 792 Lavange Lisa Common Stock
Feb 01, 2024 Buy 792 Evans Sharlene Common Stock
Jan 04, 2024 Sell 1 000 Paglia John Kenneth Common Stock
Jan 02, 2024 Buy 0 Szot Daniel
Jan 02, 2024 Sell 19 536 Woltosz Walter S Common Stock
Jan 02, 2024 Sell 464 Woltosz Walter S Common Stock
Dec 22, 2023 Buy 5 411 Dibella John Anthony Ii Common Stock
Dec 22, 2023 Sell 5 411 Dibella John Anthony Ii Common Stock
Dec 22, 2023 Sell 5 411 Dibella John Anthony Ii Stock Options (Right to Buy)
Dec 22, 2023 Sell 5 411 Dibella John Anthony Ii Common Stock
Dec 14, 2023 Sell 85 000 Woltosz Walter S Common Stock
Dec 05, 2023 Sell 7 050 Woltosz Walter S Common Stock
Dec 04, 2023 Sell 21 802 Woltosz Walter S Common Stock
Dec 01, 2023 Sell 25 025 Woltosz Walter S Common Stock
Dec 01, 2023 Sell 6 123 Woltosz Walter S Common Stock
Nov 08, 2023 Sell 1 000 Paglia John Kenneth Common Stock
Nov 02, 2023 Sell 2 720 Woltosz Walter S Common Stock
Nov 01, 2023 Sell 28 258 Woltosz Walter S Common Stock
Nov 01, 2023 Sell 29 022 Woltosz Walter S Common Stock
Nov 01, 2023 Buy 851 Paglia John Kenneth Common Stock
Nov 01, 2023 Buy 851 Weiner Daniel L Common Stock
Nov 01, 2023 Buy 851 Woltosz Walter S Common Stock
Nov 01, 2023 Buy 851 Lavange Lisa Common Stock
Nov 01, 2023 Buy 851 Evans Sharlene Common Stock
Oct 24, 2023 Sell 225 Frederick William W Stock Options (Right to Buy)
Oct 24, 2023 Buy 225 Frederick William W Common Stock
Oct 19, 2023 Buy 0 Chang Steven
Oct 19, 2023 Buy 50 000 Oconnor Shawn Stock Options (Right to Buy)
Oct 19, 2023 Buy 25 000 Frederick William W Stock Options (Right to Buy)
Oct 19, 2023 Buy 15 000 Dibella John Anthony Ii Stock Options (Right to Buy)
Oct 19, 2023 Buy 15 000 Fiedler-kelly Jill Stock Options (Right to Buy)
Oct 19, 2023 Buy 15 000 Howell Brett Stock Options (Right to Buy)
Aug 01, 2023 Buy 602 Paglia John Kenneth Common Stock
Aug 01, 2023 Buy 602 Weiner Daniel L Common Stock
Aug 01, 2023 Buy 602 Lavange Lisa Common Stock
Aug 01, 2023 Buy 602 Evans Sharlene Common Stock
Aug 01, 2023 Buy 602 Woltosz Walter S Common Stock
Jul 27, 2023 Sell 992 Lavange Lisa Common Stock
Jul 13, 2023 Sell 1 200 Paglia John Kenneth Common Stock
Jun 29, 2023 Sell 3 754 Woltosz Walter S Common Stock
Jun 28, 2023 Sell 16 246 Woltosz Walter S Common Stock
Jun 16, 2023 Buy 0 Chang Steven
May 30, 2023 Sell 10 044 Woltosz Walter S Common Stock
May 30, 2023 Sell 9 956 Woltosz Walter S Common Stock
May 01, 2023 Buy 719 Lavange Lisa Common Stock
May 01, 2023 Buy 719 Weiner Daniel L Common Stock
May 01, 2023 Buy 719 Paglia John Kenneth Common Stock
May 01, 2023 Buy 719 Evans Sharlene Common Stock
May 01, 2023 Buy 719 Woltosz Walter S Common Stock
Apr 26, 2023 Sell 17 911 Woltosz Walter S Common Stock
Apr 26, 2023 Sell 2 089 Woltosz Walter S Common Stock
Apr 03, 2023 Buy 500 Fiedler-kelly Jill Common Stock
Apr 03, 2023 Sell 500 Fiedler-kelly Jill Employee Stock Option (Right to Buy)
Mar 29, 2023 Sell 18 162 Woltosz Walter S Common Stock
Mar 29, 2023 Sell 1 838 Woltosz Walter S Common Stock
Mar 23, 2023 Buy 35 000 Dibella John Anthony Ii Common Stock
Mar 23, 2023 Sell 35 000 Dibella John Anthony Ii Stock Options (Right to Buy)
Mar 03, 2023 Buy 12 442 Dibella John Anthony Ii Common Stock
Mar 03, 2023 Sell 8 120 Dibella John Anthony Ii Common Stock
Mar 03, 2023 Sell 4 322 Dibella John Anthony Ii Common Stock
Mar 03, 2023 Sell 12 442 Dibella John Anthony Ii Stock Options (Right to Buy)
Mar 02, 2023 Sell 1 875 Frederick William W Stock Options (Right to Buy)
Mar 02, 2023 Buy 1 875 Frederick William W Common Stock
Mar 02, 2023 Buy 1 352 Dibella John Anthony Ii Common Stock
Mar 02, 2023 Buy 15 000 Dibella John Anthony Ii Common Stock
Mar 02, 2023 Sell 16 352 Dibella John Anthony Ii Common Stock
Mar 02, 2023 Sell 1 352 Dibella John Anthony Ii Stock Options (Right to Buy)
Mar 02, 2023 Sell 15 000 Dibella John Anthony Ii Stock Options (Right to Buy)
Feb 24, 2023 Sell 19 600 Woltosz Walter S Common Stock
Feb 24, 2023 Sell 400 Woltosz Walter S Common Stock
Feb 01, 2023 Buy 729 Lavange Lisa Common Stock
Feb 01, 2023 Buy 729 Weiner Daniel L Common Stock
Feb 01, 2023 Buy 729 Evans Sharlene Common Stock
Feb 01, 2023 Buy 729 Woltosz Walter S Common Stock
Feb 01, 2023 Buy 729 Paglia John Kenneth Common Stock
Jan 30, 2023 Sell 2 058 Woltosz Walter S Common Stock
Jan 30, 2023 Sell 200 Woltosz Walter S Common Stock
Jan 27, 2023 Sell 17 655 Woltosz Walter S Common Stock
Jan 27, 2023 Sell 87 Woltosz Walter S Common Stock
Dec 28, 2022 Sell 18 252 Woltosz Walter S Common Stock
Dec 28, 2022 Sell 1 748 Woltosz Walter S Common Stock
Dec 12, 2022 Sell 95 000 Woltosz Walter S Common Stock
Nov 28, 2022 Sell 19 199 Woltosz Walter S Common Stock
Nov 28, 2022 Sell 801 Woltosz Walter S Common Stock
Nov 11, 2022 Buy 703 Evans Sharlene Common Stock
Nov 11, 2022 Buy 703 Lavange Lisa Common Stock
Nov 11, 2022 Buy 703 Paglia John Kenneth Common Stock
Nov 11, 2022 Buy 703 Woltosz Walter S Common Stock
Nov 11, 2022 Buy 703 Weiner Daniel L Common Stock
INSIDER POWER
-39.752
Last 100 transactions
Buy: 243 785 | Sell: 655 613 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -39.752.

In total, the insiders bought 243 785 and sold 655 613 SLP shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Simulations Plus

Simulations Plus Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus... SLP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT